Semaglutide lowers risk of kidney failure and cardiovascular death in patients with type 2 diabetes and CKD, study results show pharmaceutical-journal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-journal.com Daily Mail and Mail on Sunday newspapers.
Patients on Eli Lilly s
weight-loss drug substantially regained weight after stopping
treatment, according to a study published in journal JAMA on
Monday. The study showed that patients.